LAWRENCE — For the second consecutive year and the third time in four years, the University of Kansas School of Pharmacy is ranked No. 2 in the nation in National Institutes of Health funding.
The School of Pharmacy earned more than $25 million in NIH research funding in fiscal year 2012 — an increase of $3 million from the previous year’s total. The NIH is a primary source of federal funding for pharmacy schools, and NIH funding is considered a key indicator of the productivity and quality of a school’s faculty.
This marks the 12th consecutive year the school has been ranked in the top five. It has been in the top 10 every year since 1995. KU is the only Big 12 institution in the top 10.
Additionally, the KU School of Pharmacy ranks No. 1 nationally in the value of awards per funded faculty member. The school's 24 NIH-funded faculty members bring in an average of more than $1 million each. Additional funding is awarded to researchers who collaborate with colleagues from other schools.
“Faculty researchers at the KU School of Pharmacy are second to none,” said Ken Audus, dean of the pharmacy school. “Year after year, they compete for and earn significant outside funding. They bring millions of dollars to the university and the state, and more important, they make discoveries that improve the lives of people throughout the world.”
The rankings are based on data collected and posted by the American Association of Colleges of Pharmacy.
KU Chancellor Bernadette Gray-Little said the NIH rankings affirm the KU School of Pharmacy's status as a national leader.
“These rankings show that our faculty are aggressive in competing for external grants and demonstrate why KU has such a strong return on investment for the state of Kansas,” said Chancellor Bernadette Gray-Little. “More important, these rankings demonstrate that our researchers are leading the way in developing new cures and therapies to improve our health and quality of life.”